Company Filing History:
Years Active: 1999
Title: Gregor Awang: Innovator in Recombinant DNA Technology
Introduction
Gregor Awang is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA molecules. His work has implications for medical advancements, especially in the production of therapeutic proteins.
Latest Patents
Gregor Awang holds a patent for "Recombinant DNA molecules and expression vectors for tissue plasminogen." This invention involves a recombinant DNA molecule designed for the transfection of host cells. It encodes mammalian erythropoietin or tissue plasminogen activator, along with an expression control sequence and at least one SAR element. The patent also covers expression vectors containing the recombinant DNA molecule and mammalian cells transformed with these vectors. These cells are capable of expressing recombinant EPO or tPA in vitro at significant levels.
Career Highlights
Awang is associated with Cangene Corporation, where he has been instrumental in advancing biotechnological research and development. His expertise in recombinant DNA technology has positioned him as a key player in the field. He has successfully contributed to projects that enhance the understanding and application of genetic engineering.
Collaborations
Gregor Awang collaborates with Genevieve Delcuve, working together to push the boundaries of biotechnology. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Gregor Awang's contributions to recombinant DNA technology highlight his role as an innovator in the biotechnology sector. His patent and work at Cangene Corporation reflect his commitment to advancing medical science through innovative solutions.